Aspira Women's Health CEO Sandford steps down; Dr. Milligan interim CEO

Aspira Women's Health Inc.

CEO Nicole Sandford departs immediately for family health matter; remains as consultant for transition.
President Dr. Sandra Milligan named interim CEO; nationwide search for permanent successor underway.
Separation: $375,000 biweekly over 9 months plus $135,000 bonus upon fundraising or by Sept 30, 2025.
Board cites Sandford's role in launching OvaWatch and securing $10M ARPA-H award for endometriosis test.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.